The US pharmaceutical supply chain relies heavily on imports, with roughly 80% of APIs sourced from China and India. 2 Tariffs could raise input costs, trigger retaliatory trade measures, or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback